Pharma Marketing Network

Attend CBI's annual conference and gain insight from the regulatory, clinical, marketing, adverse events and Post-Marketing perspectives.  The program provides a unique forum in which you can network with industry executives and Phase IV teams who can share their valuable experiences with you.

This conference provides insights into the economic implications of poor disease management and patient non-compliance.

Implementing Best Practices Towards Successful Outsourcing

The Washington post published an editorial favoring legislation to shield drug companies from punitive damages in lawsuits like the those currently faced by Merck....

Roy Vagelos, Former Chairman and CEO of Merck, gave a keynote presentation at the Pharmaceutical Marketing Congress in Philadelphia this past Tuesday. His presentation...

Article SummariescDetailing: Addressing the Consumer Education GapSteve Smith, Editor-in-Chief of Medsite has reengineered his company's eDetailing line to create engaging interactions crafted around effective...

According to Nielsen Media Research data quoted in a recent MM&M News Brief,Pfizer fell from its position as one of the nation's top 10...

On August 2, 2005, Lilly announced its support of the Pharmaceutical Research and Manufacturers Association's (PhRMA) comprehensive guiding principles on consumer advertising of prescription...

The pro-active actions of several pharmaceutical companies to aid of the victims of Katrina must be applauded.The Wall Street Journal reported today that several...

New guidelines limiting DTC on TV may mean that pharmaceutical marketers are likely to invest more effort reaching consumers via the Internet and other...